Consistent with these results, enzyme-linked immunosorent assay (ELISA) confirmed that mid and endpoint measures of serum leptin were significantly lower in HU vs. AMB mice (Fig. 2g), whereas blood panels confirmed that all mice were healthy and free of metabolic disease throughout the study time course (Supplementary Fig. S1). This evidence concerns the gene LEP and metabolic disease.